Caspofungin Acetate

醋酸卡泊芬净

Report date: 2025/10/11 17:38:35
NMEFirst In Class

Base Information

Drug NameCaspofungin Acetate
Drug Alias NameCaspofungine卡帕芬净Caspofungina卡泊芬净醋酸酯乙酸卡泊芬净 +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of Action1,3-beta-glucan synthase inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsFebrile NeutropeniaNeutropeniaNeoplasms +[11] 
Global Approved IndicationsNeutropeniaCandidiasisAspergillosis +[4] 
Approved Indications in ChinaNeutropeniaAspergillosisMycoses
Original Approved Country/TerritoryUnited States
Original Approved Date2001/01/26
Country/TerritoryBelgiumUnited StatesItaly +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme CorpMerck Sharp & Dohme BvFresenius Kabi Usa Llc +[4] 
Inactive CompaniesCttqNational Cancer InstituteUniversity Of Cologne +[5] 
Active IndicationsFebrile NeutropeniaNeutropeniaCandidiasis +[5] 
Inactive IndicationsNeoplasmsHIV InfectionsFungemia +[6] 

Other Information

ATC CodeJ02AX04
Related LinksWikipediaDrugBankKEGG